180 Life Sciences Stock Performance

ATNF Stock  USD 2.22  0.03  1.33%   
180 Life holds a performance score of 6 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 6.17, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 180 Life will likely underperform. Use 180 Life Sciences value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to analyze future returns on 180 Life Sciences.

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in 180 Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, 180 Life reported solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
1.82
Five Day Return
(3.83)
Year To Date Return
(42.20)
Ten Year Return
(99.84)
All Time Return
(99.84)
Last Split Factor
1:19
Last Split Date
2024-02-28
1
180 Life Sciences Announces CFO Resignation and New Board Appointments - TipRanks
09/12/2024
2
180 Life Sciences Corp. - Corporate Updates
10/03/2024
3
180 Life Sciences Corp. Regains Compliance with Nasdaqs Minimum Stockholders Equity Rule and Expands into the Global iGaming Sector
10/09/2024
4
ATNF Surges Over 10x Following B2C Casino Operations Plan Announcement
10/16/2024
5
Dow Jumps Over 100 Points Alcoa Profit Beats Estimates
10/17/2024
6
Insider Trading
10/24/2024
7
Elray Resources Announces Strategic Sale of Crypto iGaming Technology
10/25/2024
8
ARMISTICE CAPITAL, LLC Acquires New Stake in 180 Life Sciences C - GuruFocus.com
11/14/2024
Begin Period Cash FlowM
  

180 Life Relative Risk vs. Return Landscape

If you would invest  194.00  in 180 Life Sciences on August 28, 2024 and sell it today you would earn a total of  28.00  from holding 180 Life Sciences or generate 14.43% return on investment over 90 days. 180 Life Sciences is currently generating 3.5092% in daily expected returns and assumes 42.0281% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than 180, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days 180 Life is expected to generate 53.91 times more return on investment than the market. However, the company is 53.91 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.18 per unit of risk.

180 Life Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for 180 Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as 180 Life Sciences, and traders can use it to determine the average amount a 180 Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0835

Best PortfolioBest Equity
Good ReturnsATNF
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 42.03
  actual daily
96
96% of assets are less volatile

Expected Return

 3.51
  actual daily
70
70% of assets have lower returns

Risk-Adjusted Return

 0.08
  actual daily
6
94% of assets perform better
Based on monthly moving average 180 Life is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 180 Life by adding it to a well-diversified portfolio.

180 Life Fundamentals Growth

180 Stock prices reflect investors' perceptions of the future prospects and financial health of 180 Life, and 180 Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 180 Stock performance.

About 180 Life Performance

By analyzing 180 Life's fundamental ratios, stakeholders can gain valuable insights into 180 Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if 180 Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if 180 Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand-2.4 K-2.3 K
Return On Tangible Assets(5.48)(5.75)
Return On Capital Employed(68.46)(65.04)
Return On Assets(3.79)(3.98)
Return On Equity 156.07  163.87 

Things to note about 180 Life Sciences performance evaluation

Checking the ongoing alerts about 180 Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 180 Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
180 Life Sciences is way too risky over 90 days horizon
180 Life Sciences appears to be risky and price may revert if volatility continues
180 Life Sciences has a very high chance of going through financial distress in the upcoming years
180 Life Sciences currently holds 1.05 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity.
Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0.
180 Life Sciences currently holds about 1.63 M in cash with (10.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
180 Life Sciences has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: ARMISTICE CAPITAL, LLC Acquires New Stake in 180 Life Sciences C - GuruFocus.com
Evaluating 180 Life's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate 180 Life's stock performance include:
  • Analyzing 180 Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 180 Life's stock is overvalued or undervalued compared to its peers.
  • Examining 180 Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating 180 Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 180 Life's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of 180 Life's stock. These opinions can provide insight into 180 Life's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating 180 Life's stock performance is not an exact science, and many factors can impact 180 Life's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for 180 Stock analysis

When running 180 Life's price analysis, check to measure 180 Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 180 Life is operating at the current time. Most of 180 Life's value examination focuses on studying past and present price action to predict the probability of 180 Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 180 Life's price. Additionally, you may evaluate how the addition of 180 Life to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments